ERG and acute lymphoblastic leukemia: Although our study presents several limitations regarding the number of children with ALL and retrospective analyses, our findings strongly suggest that CK2 and ERG represent relevant molecular markers that generate a risk-adapted treatment strategy for high-risk patients with ALL, which must be confirmed by a prospective study in a larger population.